Cardiac valvulotomies are minimally invasive procedures used to repair or replace heart valves without open-heart surgery. Valvulotomes are specialized surgical tools used to score or cut the valve leaflets during cardiac valvulotomy procedures. The procedure is performed to enlarge the opening of a narrowed heart valve using valvulotomes, allowing improved blood flow. The valvulotome market is driven by the growing geriatric population worldwide who are more susceptible to valvular heart diseases. The Global Cardiac Valvulotome Market is estimated to be valued at US$ 115.8 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Cardiac Valvulotome Market Growth  are LeMaitre, INVAMED, GeoSurgical, LimFlow, Inc., B. Braun SE, Teleflex Incorporated, StarFish Product Engineering Inc., Koven Technology Canada Inc., Andramed, Zgrum Medical, BD, PEAK SURGICAL, and Symmetry Surgical Inc. The key players are focusing on new product launches and regulatory approvals to strengthen their market position. For instance, in 2019, LeMaitre Vascular Inc expanded its valvulotome portfolio with the launch of Xcela Arterial Valvulotome.

The growing geriatric population worldwide is increasing the prevalence of valvular heart diseases such as aortic stenosis, increasing the demand for cardiac valvulotomy procedures. As per the UN report, the number of people aged 60 or above is projected to grow from 962 million globally in 2017 to 2.1 billion in 2050. Furthermore, technological advancements in valvulotomes such as single-use disposable valvulotomes and steerability in valvulotomes allow efficient and safer procedures, fueling the market growth.

Market Trends

Some of the key trends in the cardiac valvulotome market include the growing popularity of percutaneous transvascular procedures and minimal invasive cardiac procedures. These procedures are associated with reduced trauma, quick recovery times, and lower risks of complications compared to open-heart surgeries. As a result, manufacturers are focusing on developing innovative valvulotomes suitable for transvascular procedures.

Another important trend is the rising demand for single-use disposable valvulotomes. Disposable valvulotomes help avoid risks of infection and cross-contamination associated with reusable devices. They also alleviate sterilization and reprocessing requirements of reusable valvulotomes. This Streamlines procedural workflows and reduces overall procedure costs.

Market Opportunities

Emerging economies in Asia Pacific and Latin America regions presents lucrative opportunities for cardiac valvulotome manufacturers. Rapidly growing geriatric population, improving access to healthcare facilities, and increasing awareness about valvular heart diseases are some factors auguring the demand for cardiac valvulotome procedures in these regions.

There is also opportunities for manufacturers in developing valvulotomes integrated with advanced technologies like robotics. Robotically assisted valvulotomes can enable improved procedural accuracy, flexibility, and control over manual valvulotomes. This supports complex procedures and presents opportunities to treat broader patient groups.

Impact of COVID-19 on Cardiac Valvulotome Market growth

The COVID-19 pandemic has negatively impacted the growth of the cardiac valvulotome market. During the initial outbreak and lockdown periods, non-emergency procedures and surgeries were postponed to prioritize COVID-19 care. This led to a decline in the demand for cardiac valvulotomes. However, as lockdowns are being lifted and healthcare systems are learning to deal with COVID-19, the number of surgeries have started increasing again. The demand for cardiac valvulotomes is expected to see steady growth over the forecast period as postponed surgeries and treatments are rescheduled. Manufacturers will have to focus on maintaining adequate supply levels to meet the rise in procedural volumes. They may also explore developing products that help reduce infection risk for both healthcare workers and patients. Telehealth solutions can aid in closely monitoring postoperative cardiac patients remotely. Overall, while the pandemic disrupted the market temporarily, strategic measures can help drive the market back towards its long-term growth trajectory in the coming years.

In terms of regions, North America accounts for the largest share of the global cardiac valvulotome market in terms of value. This is attributed to factors such as the rising geriatric population, increasing incidence of valvular heart diseases, growing obesity rates and acceptability of high-cost surgeries. Asia Pacific is expected to be the fastest growing regional market over the forecast period due to improving access to healthcare in developing economies, rising medical tourism and expanding healthcare infrastructure. Rising cardiac disorders due to lifestyle changes, growing medical devices industry and increasing disposable incomes will continue supporting the market growth in Asia Pacific region post pandemic.

Get more insights on Cardiac Valvulotome Market